| 2025 | 2024 | 2023 | 2022 | 2021 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 360,4 k € | +10.4% | 326,4 k € | +70.6% | 191,3 k € | -23.2% | 249,3 k € | +2.1% | 244,1 k € | +82.8% | 133,5 k € | +0.4% | 133,1 k € | +56.9% | 84,8 k € | -3.8% | 88,1 k € | +1.8% | 86,5 k € | -9.0% | 95,1 k € | +1.1% | 94,1 k € | |
| EBITDA | 186,4 k € | +5.8% | 176,1 k € | +79.1% | 98,3 k € | -40.5% | 165,1 k € | +14.9% | 143,7 k € | +78.6% | 80,5 k € | -16.9% | 96,8 k € | +165.5% | 36,5 k € | -10.4% | 40,7 k € | -8.4% | 44,4 k € | -25.8% | 59,9 k € | +8.0% | 55,5 k € | |
| Operating profit | 171,1 k € | +5.6% | 162,0 k € | +90.0% | 85,3 k € | -45.7% | 156,9 k € | +16.0% | 135,3 k € | +106.5% | 65,5 k € | -10.7% | 73,4 k € | +427.7% | 13,9 k € | -25.5% | 18,7 k € | -15.6% | 22,1 k € | -37.5% | 35,4 k € | -5.4% | 37,4 k € | |
| Profit/loss | 102,9 k € | +6.0% | 97,2 k € | +108.1% | 46,7 k € | -53.5% | 100,5 k € | +16.3% | 86,4 k € | +197.3% | 29,1 k € | -20.1% | 36,4 k € | +16334.4% | -224,0 € | -102.7% | 8,4 k € | +400.2% | 1,7 k € | -88.9% | 15,2 k € | -22.5% | 19,6 k € | |
| Equity | 149,0 k € | -39.4% | 246,1 k € | +0.9% | 243,9 k € | +0.7% | 242,2 k € | +0.2% | 241,7 k € | +150.7% | 96,4 k € | -10.1% | 107,3 k € | -18.1% | 130,9 k € | -7.2% | 141,2 k € | -8.5% | 154,2 k € | +1.1% | 152,5 k € | +11.1% | 137,4 k € | |
| Total assets | 551,8 k € | -10.6% | 617,5 k € | +4.8% | 589,4 k € | +28.4% | 458,8 k € | +2.8% | 446,4 k € | +55.9% | 286,4 k € | +0.9% | 283,9 k € | +5.4% | 269,2 k € | -13.1% | 309,7 k € | -6.2% | 330,2 k € | -0.4% | 331,5 k € | +12.2% | 295,4 k € | |
| Cash | 9,4 k € | -61.2% | 24,2 k € | -56.5% | 55,7 k € | +82.0% | 30,6 k € | -17.9% | 37,3 k € | +1071.8% | 3,2 k € | -46.5% | 6,0 k € | +11.2% | 5,4 k € | -21.8% | 6,8 k € | -68.0% | 21,4 k € | +30.3% | 16,4 k € | +138.5% | 6,9 k € | |
| Debts | 402,8 k € | +8.5% | 371,4 k € | +7.5% | 345,5 k € | +60.6% | 215,1 k € | +5.1% | 204,7 k € | +7.8% | 189,9 k € | +7.6% | 176,6 k € | +27.7% | 138,3 k € | -17.5% | 167,5 k € | -1.2% | 169,6 k € | -1.8% | 172,7 k € | +13.7% | 151,9 k € | |
| Staff | 2,3 | 2 | 1,9 | 2,5 | 2,4 | 0,8 | 0,8 | 0,8 | 0,9 | 0,7 | 0,6 | 1,1 | ||||||||||||
Private limited company · Antwerpen · incorporated on 31/12/1981 · 2,3 ETP
Private limited company profitable and well capitalised. Cash position declining (-61.2%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Apotheek De Gendt is a Private limited company incorporated in 1981. Its main activity is: Commerce de détail de produits pharmaceutiques. Its registered office is in Antwerpen. It employs on average 2,3 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette